| abstract |
THE INVENTION CONCERNS THE USE OF PARTICULAR ORAL DOSAGE RANGES OF THE COMPOUND (E)-7-[4-FLUOROPHENYL) -6-ISOPROPYL -2- [METHYL (METHYLSULFONYL) AMINO] PYRAMIDIN-5-YL]-(3R, 5S)-3,5-DIHYDROXYHEPT -6-ENOIC ACID OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, TO ALTER BENEFICIALLY LIPID LEVELS OR LIPID RATIONS IN A HUMAN PATIENT IN NEED THEREOF, AS WELL AS HARMACEUTICAL COMPOSITIONS OF SAID COMPOUND OR SALTS ADAPTED FOR ORAL ADMINISTRATION WHICH COMPRISE SUCH DOSAGES, AND METHODS OF PREPARATION THEREOF.FIG 1-MOST ILLUSTRATIVE DRAWINGS. (FIG.1) |